XT17
XT17 is an anthrone compound with broad-spectrum antibacterial activity. It exerts its antibacterial effect by disrupting the cell wall and inhibiting DNA synthesis. XT17 exhibits weak hemolytic activity, low cytotoxicity against mammalian cell lines, and a low frequency of drug resistance. Meanwhile, XT17 shows in vivo efficacy in a mouse corneal infection model induced by Staphylococcus aureus or Pseudomonas aeruginosa. Further docking studies have confirmed that XT17 can form a stable complex with bacterial gyrase. XT17 can be used in the research of the anti - infection field[1].
Product Specifications
UNSPSC
12352211
Target
Antibiotic; Bacterial; DNA/RNA Synthesis
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Field of Research
Infection
Smiles
O=C1C2=CC=C(OCCCNC(N)=N)C=C2OC3=C1C(OC/C=C(C)\C)=CC(OCCCNC(N)=N)=C3
Molecular Formula
C26H34N6O5
Molecular Weight
510.59
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Teichoic acids export ATP-binding protein TagH (tagH)
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Teichoic acids export ATP-binding protein TagH (tagH)
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Teichoic acids export ATP-binding protein TagH (tagH)
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Teichoic acids export ATP-binding protein TagH (tagH)
Recombinant Staphylococcus saprophyticus subsp. saprophyticus Teichoic acids export ATP-binding protein TagH (tagH)